000 | 01123 a2200325 4500 | ||
---|---|---|---|
005 | 20250513003648.0 | ||
264 | 0 | _c19810623 | |
008 | 198106s 0 0 eng d | ||
022 | _a0025-6196 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNelson, A M | |
245 | 0 | 0 |
_aSeries on pharmacology in practice. 9. Glucocorticoids in rheumatic disease. _h[electronic resource] |
260 |
_bMayo Clinic proceedings _cDec 1980 |
||
300 |
_a758-69 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aChemical Phenomena |
650 | 0 | 4 | _aChemistry |
650 | 0 | 4 |
_aConnective Tissue Diseases _ximmunology |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunosuppression Therapy |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 |
_aOsteonecrosis _xchemically induced |
650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
650 | 0 | 4 |
_aRheumatic Diseases _xdrug therapy |
650 | 0 | 4 | _aSubstance Withdrawal Syndrome |
700 | 1 | _aConn, D L | |
773 | 0 |
_tMayo Clinic proceedings _gvol. 55 _gno. 12 _gp. 758-69 |
|
999 |
_c7012119 _d7012119 |